Health
BioNTech's Gotistobart Significantly Enhances Lung Cancer Survival Rates
By Editor • September 14, 2026 • 1 min read
BioNTech's gotistobart nearly doubles lung cancer survival rates compared to chemotherapy, according to recent trial results.
Read more